Nebraska Cultures Sponsors Probiotic Study

WALNUT CREEK, Calif.Nebraska Cultures Inc., the creator and exclusive supplier of Dr. Shahanis® DDS-1 strain of L. acidophilus, is sponsoring a study on the efficacy of probiotics in human. The study, Survival and persistence of Lactobacillus acidophilus DDS-1 and other lactobacilli in human subjects, specifically seeks to determine whether healthy bacteria can survive an extended time in the human gastrointestinal (GI) tract. Because of the low pH, the presence of bile salts and the competitive environment of the human intestinal tract, questions have arisen regarding the survivability (and therefore efficacy) of probiotics as a category. For accuracy and relevance to Dr. Shahanis strain of probiotic, the study will employ human trial subjects who ingest controlled amounts of specified bacteria strains, and who are then tested after an extended period of time to see what, if any, of the bacteria can still be detected. 

With U.S. consumers spending tens of millions a year on vitamins, supplements and other holistic medicines, we feel it is important for our company to regularly revisit the topic of efficacy for our loyal customers, explained Michael Shahani, director of operations for Nebraska Cultures.  Results from this study will allow us to further refine our healthful products to better restore the natural balance of the human body.